Igarashi S, Inami H, Hara H, Fujii M, Koutoku H, Oritani H, Mase T
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan.
Chem Pharm Bull (Tokyo). 2000 Mar;48(3):382-8. doi: 10.1248/cpb.48.382.
In a search for novel nonsteroidal inhibitors of human prostatic 5alpha-reductase, we found a new series of indole derivatives that showed potent inhibitory activities for the human enzyme. Among them, 4-[(1-benzyl-1H-indol-5-yl)oxyl-3-chlorobenzoic acid (2d, YM-32906) showed more potent inhibitory activity than finasteride with an IC50 value of 0.44 nM. 3-Chloro-4-[[1-(4-phenoxybenzyl)-1H-indol-5-yl]oxy]benzoic acid (2m) showed inhibitory activities for both human and rat prostatic 5alpha-reductase with IC50 values of 2.1 and 73 nM, respectively. The synthesis and structure-activity relationships of these indole derivatives are presented.
在寻找新型人前列腺5α-还原酶非甾体抑制剂的过程中,我们发现了一系列对该人类酶显示出强效抑制活性的新型吲哚衍生物。其中,4-[(1-苄基-1H-吲哚-5-基)氧基]-3-氯苯甲酸(2d,YM-32906)显示出比非那雄胺更强的抑制活性,IC50值为0.44 nM。3-氯-4-[[1-(4-苯氧基苄基)-1H-吲哚-5-基]氧基]苯甲酸(2m)对人和大鼠前列腺5α-还原酶均显示出抑制活性,IC50值分别为2.1和73 nM。本文介绍了这些吲哚衍生物的合成及其构效关系。